The KRAS G12 mutated CRC (n = 240) and the selected KRAS wild-type CRC (n = 390) harbored APC mutation at 79.6% (191/240) and 74.9% (292/390), respectively; however, this difference that was not statistically significant (P = 0.21). Here, KRAS is linked to colorectal carcinoma.